FONR vs. VANI, HYPR, ELMD, RMTI, CUTR, ECOR, SMLR, MOVE, POCI, and PXDT
Should you be buying FONAR stock or one of its competitors? The main competitors of FONAR include Vivani Medical (VANI), Hyperfine (HYPR), Electromed (ELMD), Rockwell Medical (RMTI), Cutera (CUTR), electroCore (ECOR), Semler Scientific (SMLR), Movano (MOVE), Precision Optics (POCI), and Pixie Dust Technologies (PXDT).
FONAR (NASDAQ:FONR) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.
In the previous week, FONAR and FONAR both had 1 articles in the media. Vivani Medical's average media sentiment score of 0.68 beat FONAR's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the news media.
50.6% of FONAR shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 2.2% of FONAR shares are held by insiders. Comparatively, 55.6% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
FONAR has a net margin of 10.66% compared to Vivani Medical's net margin of 0.00%. FONAR's return on equity of 7.50% beat Vivani Medical's return on equity.
FONAR has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
FONAR has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.26, suggesting that its stock price is 226% more volatile than the S&P 500.
FONAR received 168 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 73.48% of users gave FONAR an outperform vote.
Summary
FONAR beats Vivani Medical on 9 of the 13 factors compared between the two stocks.
Get FONAR News Delivered to You Automatically
Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
